Syncona

About Syncona

Syncona Ltd is a FTSE250 life science investment company focused on founding, building, and funding healthcare businesses that develop transformational treatments for patients in areas of high unmet need. Syncona maintains a diversified portfolio of 20-25 life science companies across various development stages, modalities, and therapeutic areas. The company partners closely with academic founders and experienced management teams to deliver patient impact and long-term value.